Peetz Christopher exercised Options for 30,000 Mirum Pharmaceuticals shares and sold 30,000 shares on 2026-09-01. The reported transactions leave him with 194,440 shares and 58,487 derivative securities, while the exercise and sales carry separately stated per-share prices for investors assessing insider ownership.

Key Highlights

  • The option exercise was priced at $2.94 per share.
  • The two share-sale transactions ranged from $98.08 to $98.91 per share.
  • Christopher’s reported derivative securities ownership stood at 58,487 after the exercise.

Peetz Christopher exercised options for 30,000 Mirum Pharmaceuticals (NASDAQ: MIRM) shares and sold 30,000 shares on 1 September 2026.

Mirum Share Ownership Recorded After Transactions

Christopher’s option exercise left his reported common-share ownership at 224,440 shares before the subsequent sales. The 30,000-share disposal was completed through two separate transactions. Sale prices ranged from $98.08 to $98.91 per share. A separate option exercise involving 30,000 derivative securities left him with 58,487 derivative securities.

Exercise and Sale Prices Show Separate Per-Share Amounts

The exercise price was $2.94 per share, while the sales were executed within the $98.08 to $98.91 per-share range. The filing separately reports the $2.94 exercise price and the $98.08 to $98.91 sales range on 1 September 2026. Following the sales, Christopher’s reported ownership was 194,440 Mirum Pharmaceuticals shares.